Rare diseases
Investigational molecules
Locations
Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema
ItalyStudy Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma
ItalyStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
ItalyStudy on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia
ItalyStudy on Spesolimab for Treating Recurrent Flares in Patients with Generalized Pustular Psoriasis
ItalyStudy of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer
ItalyStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
ItalyStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
ItalyStudy on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression
ItalyStudy on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels
ItalyStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
